Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Unichem Laboratories Ltd.

Unichem Lab

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹43.97 Cr.

EX-Date	Purpose
29 05 2021	Final Dividend & Audited Results
31 07 2021	Quarterly Results
02 11 2021	Quarterly Results
29 01 2022	Quarterly Results
27 05 2022	Final Dividend & Audited Results
09 08 2022	Quarterly Results
11 11 2022	Quarterly Results
06 02 2023	Quarterly Results
23 05 2023	Audited Results
14 07 2023	Quarterly Results
01 11 2023	Quarterly Results
05 02 2024	Quarterly Results
30 09 2024	Inter alia, to consider and approve:- (1) integration and consolidation of the generics formulations business in the US market.
13 11 2024	Quarterly Results
06 02 2025	Quarterly Results
22 05 2025	Quarterly Results & Audited Results
04 08 2025	Quarterly Results

News

03-MAR-2025

USFDA concludes inspection at Unichem Laboratories’ Pithampur API facility

The said inspection conducted from February 24, 2025 to February 28, 2025

11:30 AM

05-DEC-2023

Unichem Laboratories sells balance stake in Optimus Drugs

In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures

11:18 AM

06-OCT-2022

Unichem Laboratories’ arm recalls 18,960 bottles of hypertension drug in US

The recall is due to product mix-up

11:07 AM

07-FEB-2023

Unichem Laboratories reports consolidated net loss of Rs 63.92 crore in Q3

Total consolidated income of the company decreased 2.18% at Rs 318.84 crore for Q3FY23

03:17 PM

10-AUG-2022

Unichem Laboratories gets ANDA nod for Labetalol Hydrochloride tablets

Labetalol Hydrochloride tablets are indicated for the management of hypertension

09:29 AM

11-JAN-2024

Unichem Laboratories gets ANDA approval for Doxazosin tablets

The product will be commercialized from Unichem’s Goa Plant

12:26 PM

14-JUL-2023

Unichem Laboratories’ consolidated net loss narrows to Rs 0.66 crore in Q1

Total income of the company increased by 36.02% at Rs 431.82 crore for Q1FY24

03:30 PM

14-OCT-2022

Unichem Laboratories gets ANDA approval for Extended Phenytoin Sodium Capsules

The product will be commercialized from Unichem’s Ghaziabad Plant

03:11 PM

16-AUG-2022

Unichem Laboratories gets ANDA approval for Quetiapine Extended-Release Tablets

The product will be commercialized from Unichem’s Goa Plant

12:40 PM

17-MAR-2023

Unichem Laboratories gets ANDA approval for Ranolazine Extended-Release Tablets

The product will be commercialized from Unichem’s Goa Plant

12:27 PM

20-MAR-2025

Unichem Laboratories completes capacity expansion of API plant at Pithampur

Investment made for the said capacity expansion is approximately Rs 200 crore

05:40 PM

23-AUG-2022

Unichem Laboratories gets ANDA nod for Carbamazepine Tablets

The product will be commercialized from Unichem’s Goa Plant

11:30 AM

23-JUN-2025

USFDA conducts inspection at Unichem Laboratories’ Roha API facility

The inspection closed with three observations which were more of procedural changes with none of these related to data integrity

09:50 AM

23-SEP-2024

Unichem Laboratories planning to consolidate generics formulations business in US market

The meeting of the Board of Directors of the Company scheduled to be held on September 30, 2024 to consider the same

12:58 PM

26-SEP-2022

Unichem Laboratories completes sale of 19.97% equity shares in Optimus

The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche

09:50 AM

28-JUL-2023

CCI approves acquisition of up to 59.38% stake of Unichem Laboratories by Ipca

The CCI approved the proposed combination subject to compliance of undertaking voluntarily submitted by the Parties

11:07 AM

30-AUG-2023

Unichem Laboratories gets ANDA approval for Prasugrel Tablets

The product will be commercialized from Unichem’s Goa Plant

09:58 AM